InsiderTrades

Form 4 for CRBU Caribou Biosciences, Inc.

Accepted 2026-02-24 00:00:00 ET · period of report 2026-02-20 · accession 0001891113-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-02-24 2026-02-24 CRBU Khan Ruhi Ahmad Chief Business Off S - Sale $1.96 -6,938 105.0K -6% -$13.6K
D 2026-02-24 2026-02-20 CRBU Khan Ruhi Ahmad Chief Business Off A - Grant $0.00 +45.0K 111.9K +67% $0
D 2026-02-24 2026-02-20 CRBU Khan Ruhi Ahmad Chief Business Off A - Grant $0.00 +202.5K 202.5K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-24 S D 6,938 $1.96 104,998 D — — (F2) Reflects the number of shares of common stock that were sold in a "sell-to-cover" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs.
2 Common Common Stock 2026-02-20 A A 45,000 $0.00 111,936 D — — (F1) This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date.
3 Derivative Option to purchase Common Stock 2026-02-20 A A 202,500 $0.00 202,500 D $1.80 · — to 2036-02-19 202,500 Common Stock (F3) 1/48 of the total number of shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2030, subject to the reporting person continuing to provide service to the Issuer through each such vesting date.